Ahn-Gook Pharmaceutical Co., Ltd.

Research Ahn-Gook Pharmaceutical Co., Ltd. (001540.KQ) on Bullrun: market cap KRW 112.97B, dividend yield 6.4%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is KRW 112.97B; dividend yield is 6.4%.

Peer valuation comparison

Latest dividend yield is 6.37% versus a Healthcare sector median of 2.4% (165.4% above).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18KRW 112.97Bn/a6.4%633

Dividend history

Latest trailing dividend snapshot: annual dividend/share 633 KRW, yield 6.4%.

About Ahn-Gook Pharmaceutical Co., Ltd.

Ahn-Gook Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products. The company's pharmaceutical products include Cinatura and Revo Tension. The company was founded in 1959 and is headquartered in Seoul, South Korea.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Ahn-Gook Pharmaceutical Co., Ltd.'s market cap?

Ahn-Gook Pharmaceutical Co., Ltd.'s market capitalization is KRW 112.97B.

Does Ahn-Gook Pharmaceutical Co., Ltd. pay a dividend?

Ahn-Gook Pharmaceutical Co., Ltd. has a dividend yield of 6.4%.

What does Ahn-Gook Pharmaceutical Co., Ltd. do?

Ahn-Gook Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products. The company's pharmaceutical products include Cinatura and Revo Tension. The company was founded in 1959 and is headquartered in Seoul, South Korea.